bearish
Celltrion (068270): Time Is Not Right for Short Sellers Yet
376 Views14 Aug 2018 07:09
First, let me tell you this. I'm also a Celltrion basher. I don't like their accounting practices and dual company structure. Not only that,...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Celltrion Healthcare Placement: Two Mitigating Factors, Short Healthcare But Long Celltrion18 Sep 2018
- Celltrion Healthcare Placement: Weigh Down from FDA Uncertainty and Placement Overhang18 Sep 2018
- Another Negative Sign for Celltrion: Remsima Retail Price Is Falling Too Fast Too Much30 Aug 2018
- Celltrion: Manufacturing Risks Remain08 Aug 2018
- Sell Celltrion Inc (068270 KS): Story Unravelling26 Jul 2018
- Celltrion's FDA CRL Issue Summary09 Apr 2018
x